Pila Pharma AB (ST:PILA) — Stock Price

Skr1.34 SEK
▲ 3.89% today

Pila Pharma AB (ST:PILA) is currently trading at Skr1.34 SEK, up 3.89% today. Over the past 52 weeks, shares have ranged between Skr1.10 and Skr2.53. This page tracks Pila Pharma AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see PILA market cap overview.

Pila Pharma AB (PILA) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Pila Pharma AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Pila Pharma AB Income Statement — Revenue, Profit & Earnings by Year

Pila Pharma AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr1.13 Million Skr775.00K Skr1.46 Million Skr1.88 Million Skr719.23K
Cost of Revenue Skr7.94 Million Skr8.90 Million Skr7.86 Million Skr10.77 Million Skr38.29K
Gross Profit Skr-6.82 Million Skr-8.12 Million Skr1.46 Million Skr1.88 Million Skr680.94K
Research & Development
SG&A Skr5.07 Million
Total Operating Expenses Skr1.08 Million Skr8.88 Million Skr7.86 Million Skr10.77 Million Skr9.94 Million
Operating Income Skr-7.89 Million Skr-8.11 Million Skr-6.39 Million Skr-8.89 Million Skr-9.26 Million
EBITDA Skr-15.92 Million Skr-10.11 Million Skr-8.81 Million Skr-26.76 Million Skr-17.16 Million
EBIT Skr-17.00 Million Skr-11.19 Million Skr-9.89 Million Skr-26.78 Million Skr-17.18 Million
Interest Expense Skr219.00K Skr53.00K Skr40.09K Skr658.00 Skr30.54K
Income Before Tax Skr-16.86 Million Skr-11.24 Million Skr-9.93 Million Skr-26.78 Million Skr-17.21 Million
Income Tax Expense Skr-249.00 Skr17.89 Million Skr7.95 Million
Net Income Skr-16.86 Million Skr-11.24 Million Skr-9.93 Million Skr-26.78 Million Skr-17.21 Million

Pila Pharma AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Pila Pharma AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr16.22 Million Skr6.22 Million Skr8.46 Million Skr10.89 Million Skr31.81 Million
Total Current Assets Skr16.15 Million Skr5.01 Million Skr6.24 Million Skr7.59 Million Skr28.50 Million
Cash & Equivalents
Short-term Investments
Net Receivables Skr255.00K Skr121.31K Skr281.49K Skr347.08K Skr288.23K
Inventory Skr1.00 Skr-347.08K Skr-288.23K
Property, Plant & Equipment Skr15.63K
Goodwill
Total Liabilities Skr1.43 Million Skr963.00K Skr1.79 Million Skr1.36 Million Skr1.51 Million
Total Current Liabilities Skr1.43 Million Skr962.00K Skr1.79 Million Skr1.36 Million Skr1.51 Million
Long-term Debt
Net Debt Skr-15.90 Million Skr-4.89 Million Skr-5.95 Million Skr-7.24 Million Skr-28.21 Million
Total Stockholder Equity Skr14.78 Million Skr5.26 Million Skr6.66 Million Skr9.53 Million Skr30.30 Million
Retained Earnings Skr-110.35 Million Skr-93.48 Million Skr-82.24 Million Skr-72.31 Million Skr-45.54 Million

Pila Pharma AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Pila Pharma AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr-9.19 Million Skr-7.82 Million Skr-4.85 Million Skr-9.09 Million Skr-9.36 Million
Capital Expenditures Skr0.00 Skr4.00 Skr0.00 Skr0.00 Skr0.00
Free Cash Flow Skr-9.19 Million Skr-7.82 Million Skr-4.85 Million Skr-9.09 Million Skr-9.36 Million
Investing Cash Flow
Financing Cash Flow Skr20.19 Million Skr6.76 Million Skr3.56 Million Skr-11.88 Million Skr35.67 Million
Dividends Paid
Stock-Based Compensation
Depreciation Skr1.08 Million Skr15.63K Skr20.15K
Change in Cash Skr11.01 Million Skr-1.06 Million Skr-1.29 Million Skr-20.97 Million Skr26.30 Million

Pila Pharma AB Earnings History — EPS Actual vs. Analyst Estimates

Track Pila Pharma AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Feb 28, 2024 -0.06
Oct 25, 2023 -0.08
Aug 23, 2023 -0.17
Apr 26, 2023 -0.22
Dec 31, 2022 -0.21
Oct 26, 2022 -0.36
Aug 26, 2022 -0.39
Apr 26, 2022 -0.63